Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
NCT03606408
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
127
Enrollment
INDUSTRY
Sponsor class
Conditions
Cushing's Syndrome
Interventions
DRUG:
osilodrostat
Sponsor
RECORDATI GROUP